Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 37.77

From 52W high−24.97%

Volume7.20M

Market capCNY 3.61B

P/E (TTM)−10.8x

P/S (TTM)9.1x

Div yield—

Key dataSep 18, 2026

Open

CNY 37.77

From 52W high

−24.97%

Volume

7.20M

Market cap

CNY 3.61B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−15.9x

P/E (TTM)

−10.8x

RSI (14)

51.8

MomentumView details →

1D Return

−2.75%

YTD Return

+85.30%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

−10.8x

EV/EBITDA

−15.9x

EV/Sales

9.9x

P/S (TTM)

9.1x

P/B (TTM)

5.3x

ProfitabilityView details →

Gross Margin

27.40%

Net Margin

−66.62%

EBITDA Margin

−62.47%

ROE (TTM)

−54.11%

ROA (TTM)

−17.32%

Asset Turnover

0.25x

GrowthView details →

Revenue YoY

−20.22%

EPS YoY

—

FCF YoY

+79.19%

Revenue CAGR 3Y

−1.39%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−2.75%

YTD Return

+85.30%

1Y Return

+67.46%

RSI (14)

51.8

vs 50D SMA

+5.43%

vs 200D SMA

+21.73%

Capital & dividendView details →

Debt/Equity

0.68x

Current Ratio

0.63x

Quick Ratio

0.41x

Div Yield

—

Div Rate

—

Div Growth 1Y

+5.71%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

443.29M

Net Income (TTM)

−295.33M

Op. CF (TTM)

32.38M

Latest newsMore news →

Shanghai Chuangxiangying Enterprise Management Partnership (Limited Partnership), a shareholder holding more than 5% of Kanghui Co., completed its share reduction plan, selling 998,800 shares via centralized bidding from July 16 to August 31, 2026, reducing its stake from above 5% to 4.69%.19d ago

Kanghui Co., Ltd. announced its first-half 2026 results: net profit attributable to shareholders was 9.0925 million yuan, turning from a loss in the same period of 2025.23d ago

Similar companies

威尔药业603351.SH 司太立603520.SH 灵康药业603669.SH Shandong Xinhua Pharmaceutical Company Limited00719.HK 卫信康603676.SH 益佰制药600594.SH Find similar companies →

Latest newsMore news →

Shanghai Chuangxiangying Enterprise Management Partnership (Limited Partnership), a shareholder holding more than 5% of Kanghui Co., completed its share reduction plan, selling 998,800 shares via centralized bidding from July 16 to August 31, 2026, reducing its stake from above 5% to 4.69%.19d ago Kanghui Co., Ltd. announced its first-half 2026 results: net profit attributable to shareholders was 9.0925 million yuan, turning from a loss in the same period of 2025.23d ago